Vaccine Response and Immunotherapeutics SWG

$65,409P30FY2025AINIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Paper 39720558 Paper 39702174 Paper 39606438 Paper 39604070 Paper 39591540 Paper 39566475 Paper 39499418 Paper 39478231 Paper 39465466 Paper 39453876 Paper 39434090 Paper 39431507 Paper 39417110 Paper 39377755 Paper 39339891 Paper 39323905 Paper 39292312 Paper 39272091 Paper 39236183 Paper 39234877 Paper 39189957 Paper 39134398 Paper 39079500 Paper 39078934 Paper 39022392 Paper 39008632 Paper 38916675 Paper 38913762 Paper 38904142 Paper 38864578 Paper 38861707 Paper 38837275 Paper 38828583 Paper 38826404 Paper 38798894 Paper 38798374 Paper 38794860 Paper 38776334 Paper 38758571 Paper 38735585 Paper 38726866 Paper 38720307 Paper 38720248 Paper 38712261 Paper 38712115 Paper 38659145 Paper 38613093 Paper 38597840 Paper 38585794 Paper 38583461 Paper 38561602 Paper 38539112 Paper 38519443 Paper 38507583 Paper 38496644 Paper 38490264 Paper 38474837 Paper 38459720 Paper 38421512 Paper 38408761 Paper 38382770 Paper 38349228 Paper 38346420 Paper 38298201 Paper 38278966 Paper 38270554 Paper 38254198 Paper 38245684 Paper 38232978 Paper 38228564 Paper 38215160 Paper 38190604 Paper 38189332 Paper 38169427 Paper 38157431 Paper 38131623 Paper 38123897 Paper 38114162 Paper 38113102 Paper 38109334 Paper 38079216 Paper 38061376 Paper 38058459 Paper 38052974 Paper 38039322 Paper 38032752 Paper 38019657 Paper 37988634 Paper 37977197 Paper 37976053 Paper 37976040 Paper 37963086 Paper 37955826 Paper 37879092 Paper 37844236 Paper 37831675 Paper 37831615 Paper 37830105 Paper 37790378 Paper 37788619

Abstract

The Vaccine Response and Immunotherapeutics (VRI) Scientific Working Group was added to the CFAR in 2021 to foster research related to vaccines and other immunotherapeutics for people living with HIV (PLWH). HIV researchers at JHU recognize the importance of including PLWH in vaccine studies that both are and are not specific to HIV prevention and therapeutics. The immunosuppressive consequences of HIV on the effectiveness and durability of vaccine protection is not well characterized and is an important area of research. Clinical research evaluating the durability and cellular immune responses to childhood and other adult vaccines is critical to determining if current vaccine schedules and recommendations are appropriate for PLWH. This SWG will focus on HIV and non-HIV vaccines and immunotherapeutics for PLWH to promote vaccine science education, foster research interest in vaccines and immunotherapeutics among early- and mid-level faculty, and coordinate with other SWGs to achieve these goals.

View original record on NIH RePORTER →